DaniallMasood at 15:53, 10 December 2025

2025-12-10T15:53:24Z

← Older revision		Revision as of 15:53, 10 December 2025
Line 86:		Line 86:

	EX differential expression of TNMD; <nowiki>https://biomarkerkb.org/canonical/BB1486</nowiki>		EX differential expression of TNMD; <nowiki>https://biomarkerkb.org/canonical/BB1486</nowiki>

	//

	~~ID mutation~~

	~~AC AS-0003~~

	~~DE A change in a sequence or structure in comparison to a reference entity~~

	~~DE due to an insertion, deletion or substitution event.~~

	~~DE within a biomarker entity.~~

	~~EQ MI:0118; mutation~~

	~~EX presence of rs11571833 mutation in BRCA2;~~

	~~EX <nowiki>https://biomarkerkb.org/biomarker/AN7363-3</nowiki>~~

	//		//

DaniallMasood at 15:52, 10 December 2025

2025-12-10T15:52:20Z

← Older revision		Revision as of 15:52, 10 December 2025
Line 1:		Line 1:
			[[Biomarker Entity Types Controlled Vocabulary]]

			[[Biomarker Reporting Terms Controlled Vocabulary]]

			[[Biomarker Modifications Terms Controlled Vocabulary]]

	<nowiki>---------------------------------------------------------------------------</nowiki>		<nowiki>---------------------------------------------------------------------------</nowiki>

DaniallMasood: made aspect controlled vocab page

2025-11-06T19:26:41Z

made aspect controlled vocab page

New page

<nowiki>---------------------------------------------------------------------------</nowiki>

BiomarkerKB Controlled Vocabulary:

Biomarker Aspect Controlled Vocabulary File

Biomarker Knowledgebase Project

<nowiki>---------------------------------------------------------------------------</nowiki>

Description: Controlled vocabulary of standardized aspects used to describe

the specific measurable or biological feature of a biomarker entity.

Name: aspect.txt

Release: 2025_07_16

<nowiki>---------------------------------------------------------------------------</nowiki>

This document lists controlled terms that represent measurable or

definable aspects of a biomarker entity. These terms indicate what

property, modification, or characteristic of the biomarker is being

evaluated, enabling structured representation of natural language

phrases such as "increased IL6 level" or "presence of BRCA2 mutation".

Each entry consists of the following line codes:

---- ---------- --------------------------- ---------------------------------

Code Name Content Occurrences

---- ---------- --------------------------- ---------------------------------

ID Identifier Aspect term Once; starts an entry

AC Accession Unique identifier (AS-xxxx) Once

DE Definition Definition/description Once; line wrapping possible

HI Hierarchy Optional; zero or more

EQ Equivalent External identifier with Optional; zero or more

same meaning

EX Example Optional; zero or once

NT Notes Optional; zero or once; line

wrapping possible

// Terminator End of entry Once; ends an entry

<nowiki>---------------------------------------------------------------------------</nowiki>

ID level

AC AS-0001

DE A position on a scale measuring intensity, quality, or amount.

EQ NCIT:C25554; Level

EX increased IL6 level; <nowiki>https://biomarkerkb.org/canonical/AN6278</nowiki>

//

ID expression

AC AS-0002

DE Production level or transcriptional activity of a gene or RNA molecule.

EQ GO:0010467; gene expression

EX differential expression of TNMD; <nowiki>https://biomarkerkb.org/canonical/BB1486</nowiki>

//

ID mutation

AC AS-0003

DE A change in a sequence or structure in comparison to a reference entity

DE due to an insertion, deletion or substitution event.

DE within a biomarker entity.

EQ MI:0118; mutation

EX presence of rs11571833 mutation in BRCA2;

EX <nowiki>https://biomarkerkb.org/biomarker/AN7363-3</nowiki>

//

Biomarker Aspect Terms Controlled Vocabulary - Revision history

DaniallMasood at 15:53, 10 December 2025

DaniallMasood at 15:52, 10 December 2025

DaniallMasood: made aspect controlled vocab page